| Autor: |
Linthorst, Gabor E, Vedder, Anouk C, Ormel, Els E, Aerts, Johannes M F G, Hollak, Carla E M |
| Zdroj: |
Nephrology Dialysis Transplantation; February 2006, Vol. 21 Issue: 2 p355-360, 6p |
| Abstrakt: |
Recently, chronic supplementation with alpha-galactosidase A (alphaGal A) has been approved as a treatment modality for Fabry disease. The aim of the current study was to investigate the feasibility of home therapy for Fabry disease during a follow-up of >3 years and to make a proposal for practice guidelines. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
